IGEN International Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International

IGEN 0.0001000

0.0%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Renee who wrote (344)	5/7/1998 10:24:00 PM
From: John Zwiener	Read Replies (1) of 1025

Renee, this is a good example of the potential. But it is the next generation of targets, ligands, and intracellular hormones, and stats,etc., where Igen has the advantage. These things cost a fortune to screen. So the first one to screen these things will have a head start on these super specific compounds. I suspect that pfizers library has done much, much more than doubled.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next